Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomy

Pathologic and Clinical Findings to Predict Tumor Extent of Nonpalpable (Stage T1 c) Prostate Cancer

Jonathan I. Epstein · JAMA · 1994 · 1.8K citations

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

Fritz H. Schröder, Jonas Hugosson, Monique J. Roobol et al. · The Lancet · 2014 · 1.5K citations · Full text

Prostate Cancer Mortality, Urology, Cancer Epidemiology +7

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

Jonas Hugosson, Sigrid Carlsson, Gunnar Aus et al. · The Lancet Oncology · 2010 · 925 citations · Full text

Urology, Cancer Epidemiology, Cancer Screening +7

APTIMA PCA3 Molecular Urine Test: Development of a Method to Aid in the Diagnosis of Prostate Cancer

Jack Groskopf, Sheila M. J. Aubin, Ina L. Deras et al. · Clinical Chemistry · 2006 · 526 citations · Full text

A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range

William J. Catàlona, Alan W. Partin, Martin G. Sanda et al. · The Journal of Urology · 2011 · 486 citations · Full text